LIMN
Liminatus Pharma, Inc. Class A Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Liminatus Pharma (LIMN) Stock: Buy, Sell, or Hold?
$2.94
+0.17 (+6.14%)
▲
5d:
+5.21%
30d:
-13.78%
90d:
+1861.31%
QUANTITATIVE VERDICT
BUY
HIGH Confidence (91%)
Quality Score
60/100
Position
FAIR
30-Day Fair Range
$2.72 – $3.51
Position: FAIR
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.40 / $3.14
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
✅ BUY SIGNAL: LIMN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Get Alerted When LIMN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: LIMN is currently trading at $2.94, which is considered fair relative to its 30-day fair value range of $2.72 to $3.51.
Technical Outlook: Technically, LIMN is in a strong uptrend. Immediate support is located at $2.40, while resistance sits at $3.14. The stock is showing strong short-term momentum, up 6.1% recently.
Market Sentiment: LIMN scores 80/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LIMN is in a strong uptrend. Immediate support is located at $2.40, while resistance sits at $3.14. The stock is showing strong short-term momentum, up 6.1% recently.
Market Sentiment: LIMN scores 80/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.72 -
$3.51
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
91.2%
Trading Range & Key Levels
30-Day Trading Range
$2.72 -
$3.51
Current vs Trading Range
FAIR
Support Level
$2.40
Resistance Level
$3.14
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (80/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.1%)
- BULLISH: Bottoming setup score 80/100 — corrected, stabilizing, and turning up
Fundamental Context
Share LIMN Analysis
Share this live LIMN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (LIMN)
Bullish
3 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Oct 14, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages suggest a bullish sentiment towards $LIMN, with traders recommending buying the dip based on similarities to $QTEX and $DXF.
Key Retail Themes:
Buy the dip
Comparison to other stocks
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 8:20 AM ET
Data refreshes hourly during market hours. Next update: 9:20 AM
Data refreshes hourly during market hours. Next update: 9:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LIMN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 56 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 35 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 62 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive LIMN Research Pages